Arsenic trioxide: Pharmacokinetics in acute promyelocytic leukemia (APL) patients

被引:0
|
作者
Ghiuzeli, Cristina Maria
Calabro, Anthony
Saunders, Randall Jesse
Budman, Daniel R.
Styblo, Miroslav
Devoe, Craig E.
Allen, Steven L.
机构
[1] Hofstra North Shore LIJ Sch Med, Lake Success, NY USA
[2] Univ N Carolina, Chapel Hill, NC USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
7055
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Role of Arsenic Trioxide in Acute Promyelocytic Leukemia
    Harry J. Iland
    John F. Seymour
    Current Treatment Options in Oncology, 2013, 14 : 170 - 184
  • [22] Arsenic trioxide for the treatment of acute promyelocytic leukemia
    Lam, MSH
    Ignoffo, RJ
    CANCER PRACTICE, 2001, 9 (03) : 155 - 157
  • [23] Treatment of Molecular and Clinical Relapse of Acute Promyelocytic Leukemia (APL) with Arsenic Trioxide: Results of the European Registry of Relapsed APL
    Lengfelder, Eva
    Lo-Coco, Francesco
    Montesinos, Pau
    Grimwade, David
    Ades, Lionel
    Kishore, Bhuvan
    Pagoni, Maria
    Ramadan, Safaa M.
    Breccia, Massimo
    Holowiecka, Alexandra
    Pradel, Anne
    Sauerland, Maria Cristina
    Fenaux, Pierre
    Angel Sanz, Miguel
    BLOOD, 2010, 116 (21) : 12 - 12
  • [24] Time course of arsenic species in red blood cells of acute promyelocytic leukemia (APL) patients treated with single agent arsenic trioxide
    Guo, Meihua
    Wang, Bin
    Liu, Shuchuan
    Wang, Wenjing
    Gao, Chunlu
    Hu, Shuang
    Fan, Shengjin
    Hai, Xin
    Zhou, Jin
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (04) : 371 - 378
  • [25] Oral arsenic trioxide for relapsed acute promyelocytic leukemia in pediatric patients
    Au, Wing Y.
    Li, Chi-Kong
    Lee, Vincent
    Yuen, Hui Leung
    Yau, Jeffrey
    Chan, Godfrey C. F.
    Ha, Shau-yin
    Kwong, Yok-lam
    PEDIATRIC BLOOD & CANCER, 2012, 58 (04) : 630 - 632
  • [26] Pharmacokinetic of arsenic trioxide in newly diagnosed acute promyelocytic leukemia patients
    Hosseini, R.
    Mandegary, A.
    Alimoghaddam, K.
    Ghavamzadeh, A.
    Ghahremani, M.H.
    Journal of Applied Sciences, 2008, 8 (24) : 4617 - 4623
  • [27] Evaluation of Mechanisms of Resistance to Arsenic Trioxide in Patients with Acute Promyelocytic Leukemia
    Chendamarai, Ezhilarasi
    Abu Alex, Ansu
    Ganesh, Saravanan
    Lakshmi, Kavitha M.
    Jadhav, Sachin
    George, Biju
    Abraham, Aby
    Balasubramanian, Poonkuzhali
    Ramachandran, Shaji
    Srivastava, Alok
    Mathews, Vikram
    BLOOD, 2010, 116 (21) : 1132 - 1133
  • [28] Clinical pharmacokinetic study of arsenic trioxide in an acute promyelocytic leukemia (APL) patient: Speciation of arsenic metabolites in serum and urine
    Fukai, Yasuomi
    Hirata, Miyuki
    Ueno, Mayumi
    Ichikawa, Naoaki
    Kobayashi, Hikaru
    Saitoh, Hiroshi
    Sakurai, Teruaki
    Kinoshita, Kenji
    Kaise, Toshikazu
    Ohta, Shin
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2006, 29 (05) : 1022 - 1027
  • [29] Advances in management of acute promyelocytic leukemia with arsenic trioxide
    Jun, Ma
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2007, 13 (02) : 92 - 94
  • [30] Arsenic trioxide in the treatment of advanced acute promyelocytic leukemia
    Carmosino, I
    Latagliata, R
    Avvisati, G
    Breccia, M
    Finolezzi, E
    Lo Coco, F
    Petti, MC
    HAEMATOLOGICA, 2004, 89 (05) : 615 - 617